Back to ALNY

Prosight Management, LP → ALNY

Prosight Management, LP ALNY Position History

Alnylam Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$9.1M
Q3 2026
Peak value
$29.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$6.8M
Q1 2026$25.1M
Q2 2026$29.5M
Q3 2026$9.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$9.1M37.0K——
Q2 2026$29.5M98.1K——
Q1 2026$25.1M76.0K——
Q4 2025$6.8M17.1K——

Other funds holding ALNY

Other Prosight Management, LP positions

GLPGF

LAKEFRONT BIOTHERAPEUTICS NV

$61.3M
GLPGF

LAKEFRONT BIOTHERAPEUTICS NV

$59.3M
JANX

JANUX THERAPEUTICS INC

$58.4M
NKTR

NEKTAR THERAPEUTICS

$56.5M
BSX

BOSTON SCIENTIFIC CORP

$54.2M
NKTR

NEKTAR THERAPEUTICS

$52.9M
STTK

SHATTUCK LABS INC

$52.2M
JANX

JANUX THERAPEUTICS INC

$50.9M